ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Grifols Egypt for Plasma Derivatives
The Medical Science Liaison serves as a scientific bridge between the pharmaceutical company and the medical community, delivering unbiased clinical information and fostering relationships with key opinion leaders. The role involves supporting medical education, clinical trials, real‑world evidence generation, and ensuring compliance with regulatory and ethical standards.
Grifols Egypt for Plasma Derivatives (GEPD) is dedicated to enhancing the health and well-being of Egyptians by providing access to safe, high-quality lifesaving medicines derived from human plasma. The company is building a national, world-class integrated plasma infrastructure to treat rare, chronic, and life-threatening diseases. GEPD is the region's first plasma value chain to obtain EMA certification, operating within Egypt's healthcare system.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Grifols Egypt for Plasma Derivatives.
Grifols Egypt for Plasma Derivatives didn’t post a salary, so this is our estimate from similar listings.
20% below the average for this role